Cite
HARVARD Citation
Tefferi, A. et al. (n.d.). Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis. American journal of hematology. 93 (5), pp. 649-654. [Online].